Veristat and Molecular Templates Inc. enter into Preferred Provider Agreement for Refractory non-Hodgkin’s B-Cell Lymphoma trial
Veristat and Molecular Templates Inc. enter into Preferred Provider Agreement for Refractory non-Hodgkin’s B-Cell Lymphoma trial


